Systemic lupus erythematosus (SLE) is a chronic autoimmune disease linked to profound defects in the function and phenotype of T lymphocytes. Here, we describe abnormal signaling pathways that have been documented in T cells from patients with SLE and discuss how they impact gene expression and immune function, in order to understand how they contribute to disease development and progression
Systemic lupus erythematosus (SLE) is a complex autoimmune disease of unknown etiology that involves...
International audienceSystemic lupus erythematosus (SLE) is a heterogeneous disease in which excessi...
T cells from patients with systemic lupus erythematosus exhibit a notable array of defects that prob...
Systemic lupus erythematosus (SLE) is a chronic multi-organ debilitating autoimmune disease, which m...
T cells from patients with systemic lupus erythematosus display numerous signalling abnormalities. T...
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by a loss of to...
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the presence of autoant...
Systemic lupus erythematosus (SLE) is characterized by the production of a wide array of autoantibod...
Systemic lupus erythematosus (SLE) is an autoimmune disease that is characterized by the overproduct...
A wealth of T- and B-cell abnormalities has been described in systemic lupus erythematosus (SLE). In...
© 2018 Recent advances in the field of autoimmunity have identified numerous dysfunctional pathways ...
Systemic lupus erythematosus (SLE) is a heavily female-biased, chronic and multifactorial autoimmune...
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by a loss of to...
Systemic lupus erythematosus (SLE) is a complex autoimmune disease of unknown etiology that involves...
IL-2 production is decreased in systemic lupus erythematosus (SLE) patients and affects T cell funct...
Systemic lupus erythematosus (SLE) is a complex autoimmune disease of unknown etiology that involves...
International audienceSystemic lupus erythematosus (SLE) is a heterogeneous disease in which excessi...
T cells from patients with systemic lupus erythematosus exhibit a notable array of defects that prob...
Systemic lupus erythematosus (SLE) is a chronic multi-organ debilitating autoimmune disease, which m...
T cells from patients with systemic lupus erythematosus display numerous signalling abnormalities. T...
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by a loss of to...
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the presence of autoant...
Systemic lupus erythematosus (SLE) is characterized by the production of a wide array of autoantibod...
Systemic lupus erythematosus (SLE) is an autoimmune disease that is characterized by the overproduct...
A wealth of T- and B-cell abnormalities has been described in systemic lupus erythematosus (SLE). In...
© 2018 Recent advances in the field of autoimmunity have identified numerous dysfunctional pathways ...
Systemic lupus erythematosus (SLE) is a heavily female-biased, chronic and multifactorial autoimmune...
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by a loss of to...
Systemic lupus erythematosus (SLE) is a complex autoimmune disease of unknown etiology that involves...
IL-2 production is decreased in systemic lupus erythematosus (SLE) patients and affects T cell funct...
Systemic lupus erythematosus (SLE) is a complex autoimmune disease of unknown etiology that involves...
International audienceSystemic lupus erythematosus (SLE) is a heterogeneous disease in which excessi...
T cells from patients with systemic lupus erythematosus exhibit a notable array of defects that prob...